nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Casiopeina III-Ea, a copper-containing small molecule, inhibits the in vitro growth of primitive hematopoietic cells from chronic myeloid leukemia
|
Chavez-Gonzalez, Antonieta |
|
2017 |
52 |
C |
p. 8-19 12 p. |
artikel |
2 |
Computational drug treatment simulations on projections of dysregulated protein networks derived from the myelodysplastic mutanome match clinical response in patients
|
Drusbosky, Leylah |
|
2017 |
52 |
C |
p. 1-7 7 p. |
artikel |
3 |
Conserved hierarchical gain of chromosome 4 is an independent prognostic factor in high hyperdiploid pediatric acute lymphoblastic leukemia
|
Vojcek, Á. |
|
2017 |
52 |
C |
p. 28-33 6 p. |
artikel |
4 |
Corrigendum to “BCL11A expression in acute phase chronic myeloid leukemia” [Leuk. Res. 47 (2016) 88–92]
|
Yin, Jiawei |
|
2017 |
52 |
C |
p. 67- 1 p. |
artikel |
5 |
Editorial board and publication information
|
|
|
2017 |
52 |
C |
p. IFC- 1 p. |
artikel |
6 |
Erythropoietin administration is associated with improved T-cell properties in patients with myelodysplastic syndromes
|
Deshet-Unger, Naamit |
|
2017 |
52 |
C |
p. 20-27 8 p. |
artikel |
7 |
MicroRNA-181 contributes to downregulation of SAMHD1 expression in CD4+ T-cells derived from Sèzary syndrome patients
|
Kohnken, Rebecca |
|
2017 |
52 |
C |
p. 58-66 9 p. |
artikel |
8 |
PRAME overexpression predicted good outcome in pediatric B-cell acute lymphoblastic leukemia patients receiving chemotherapy
|
Zhang, Yan-Huan |
|
2017 |
52 |
C |
p. 43-49 7 p. |
artikel |
9 |
Recent advances in the treatment of lower-risk non-del(5q) myelodysplastic syndromes (MDS)
|
Almeida, Antonio |
|
2017 |
52 |
C |
p. 50-57 8 p. |
artikel |
10 |
Subcellular localization of the FLT3-ITD oncogene plays a significant role in the production of NOX- and p22phox-derived reactive oxygen species in acute myeloid leukemia
|
Moloney, Jennifer N. |
|
2017 |
52 |
C |
p. 34-42 9 p. |
artikel |